1. 1. World Health Organization. (2017). Global hepatitis report 2017. World Health Organization.
2. 2. Popovich, V. P. (2011) Research of the Range of Hepatoprotectors in the Pharmaceutical Market of Ukraine. Pharmacology and Drug Toxicology, 1(20), 75-81.
3. 3. Popovich, V. P., Gromovik, B. P., & Glukhovsky, P. V. (2012). Market segment of hepatoprotectors in group and individual measurements. Pharmacology and Drug Toxicology, 1(26), 72-76.
4. 4. Reyes-Arellano, A., Gómez-García, O., & Torres-Jaramillo, J. (2016). Synthesis of Azolines and Imidazoles and their Use in Drug Design. Med. Chem.(Los Angeles), 6, 561-570.
5. 5. Rud, A. M., Kaplaushenko, A. G., Pruglo, E. S., & Frolova, Y. S. (2017). Hepatoprotective activity of 1, 2, 4-triazole-3-thione derivatives, which contains on C5-atomic carbon hydroxy (phenyl) methyl dependent. Farmatsevtychnyi zhurnal, (5-6), 55-63.